News for Providers
Top stories summarized by our editors
10/18/2018

Insect and arthropod losses appear to be more widespread than previously believed, and insectivore populations are plummeting along with them, according to a study published in Proceedings of the National Academy of Sciences. The loss of insects and arthropods could affect crops that depend on pollinators, scientists warn.

10/18/2018

The Canadian Pork Council revised its policy on vaccines and veterinary drugs in response to new regulations restricting the use of some medically important antimicrobials. "Most pork producers have an active ongoing relationship with a veterinarian and have adopted the changes," said Manitoba Pork quality assurance and animal care manager Mark Fynn.

10/18/2018

A study in the Journal of Diabetes Investigation showed that lean older type 2 diabetes patients had a significant improvement in glycated albumin and ratio of glycated albumin to A1C 12 weeks after taking 0.5 mg repaglinide three times daily, compared with those on sulfonylurea. Japanese researchers recruited 52 adults ages 60 to 90 and found an association between lower sulfonylurea dose and improved glycated albumin in the repaglinide group.

More Summaries:
repaglinide
10/18/2018

Australian researchers conducted a meta-analysis of 39 studies involving 359,783 diabetes patients and found those with stress hyperglycemia were at an increased risk for poorer outcomes after stroke and mortality, compared with the general population. The findings in the Journal of Diabetes Investigation revealed that those with high A1C levels had higher mortality rates and stroke recurrence and severity.

More Summaries:
stress hyperglycemia
10/18/2018

Seventy-nine percent of adults with prediabetes had a weight loss of at least 8% after an initial two-month intensive weight loss program using low-calorie meal substitutes, while 96% of those who remained in the study over three years did not develop type 2 diabetes and 22% no longer had prediabetes. The findings were based on a cohort of 2,326 adults, ages 25 to 70, and presented at the European Association for the Study of Diabetes annual meeting.

10/18/2018

A Kaiser Family Foundation survey found 71% of people said health care was very important to their decision about which congressional candidates they will vote for in the upcoming midterm elections, and 30% said it was the most important issue. Results from Florida and Nevada, considered battleground states, showed voter support for maintaining the Affordable Care Act's protection for people with pre-existing conditions.

Full Story:
Kaiser Health News
10/18/2018

Tony Johnson did not have biotech experience when he took the CEO job at Goldfinch Bio, but he saw an opportunity to do something big pharmaceutical companies had not done: use precision medicine to develop drugs for kidney disease. Goldfinch Bio's drug pipeline is based on its Kidney Genome Atlas of genetic data, and Johnson said the approach is pathway specific, selecting patients for treatments based on what is driving their disease.

Full Story:
FierceBiotech
More Summaries:
Goldfinch Bio, kidney disease
10/18/2018

A Navigant study found US health systems spent $25 billion more than they needed to on supply chain operations because they did not invest enough in them. Rob Austin of Navigant said health care executives have to engage clinicians and have more people trained in supply chain management, even if they are not from the health care sector.

Full Story:
HealthLeaders Media
More Summaries:
Navigant, Rob Austin
10/18/2018

The San Francisco-based startup's platform aids care coordinators to assess and identify both clinical and sociodemographic risk factors for chronic illnesses like diabetes, COPD, chronic kidney disease, depression and congestive heart failure. "We're training our algorithm to think like a physician to empower nonclinical staff on how to get information from a patient," says William Jack, Remedy CEO.

Full Story:
MedCity News
More Summaries:
COPD, diabetes
10/18/2018

Alloimmunized women with a known K-positive fetus and a titer of 4 or higher need intensive clinical monitoring.